Rheumatology International

Papers
(The median citation count of Rheumatology International is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study56
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study44
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases39
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review38
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination33
Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients24
Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based review23
A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient21
The efficacy and safety of extracorporeal shock wave therapy on plantar fasciitis in patients with axial spondyloarthritis: a double-blind, randomized controlled trial20
Evaluation of the prevalence of musculoskeletal conditions in consecutive patients with skin psoriasis: a descriptive cross-sectional study20
The continuum of art and rheumatology: a discernment of mutual inclusivity18
Non-disease specific patient-reported outcome measures of health-related quality of life in juvenile idiopathic arthritis: a systematic review of current research and practice16
Rituximab and intravenous immunoglobulin treatment in PM/Scl antibody-associated disease: case-based review16
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials11
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study11
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study11
The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey11
Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis11
Patients with rheumatic diseases are ready to use social media in clinical practice; what about rheumatologists? A cross-sectional survey9
0.22116184234619